Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS

被引:1
作者
Jin, Xiu [1 ]
Liu, Feifei [1 ]
Zhang, Ya [2 ]
Ma, Yingying [3 ]
Yang, Linqing [3 ]
Wang, Yunfei [3 ]
Liu, Ying [3 ]
机构
[1] Jining Med Univ, Affiliated Hosp, Dept Pathol, Jining, Shandong, Peoples R China
[2] Jining Med Univ, Affiliated Hosp, Dept Obstet, Jining, Shandong, Peoples R China
[3] Jining Med Univ, Dept Gynecol, Affiliated Hosp, Jining, Shandong, Peoples R China
关键词
Cervical cancer; ASCUS; HPV E6/E7 mRNA; Menopause; Colposcope; CERVICAL-CANCER; PREVENTION; WOMEN; PERFORMANCE; POPULATION; LESIONS;
D O I
10.1186/s12905-023-02599-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To investigate the infection status of high-risk human papillomavirus (HR-HPV) E6/E7 mRNA in patients with a cytological diagnosis of "atypical squamous cells of undetermined significance" (ASCUS) and to analyze the pathogenic rate of different high-risk HPV subtypes combined with biopsy pathological results to provide a more accurate basis for managing ASCUS patients.Methods A total of 1387 patients with ASCUS and HPV E6/E7 mRNA positivity who were referred for colposcopy were retrospectively analyzed. They were divided into HPV16+, 18/45 + and other HR-HPV + groups premenopausal and postmenopausal groups. The pathological results of the biopsy were divided into the LSIL- group (including normal and low-grade squamous intraepithelial lesions) and the HSIL + group (including high-grade squamous intraepithelial lesions and higher lesions). SPSS was used for the analysis.Results The age group 31-40 years had the highest level of HPV16+, and HPV18/45 + was the highest in the 41-50 years group. The detection rates of HSIL + in the HPV16+, HPV18/45+, HPV 16/18/45 + and Other HR-HPV + groups were 48.4%, 18.8%, 43.9% and 15.0%, respectively. The infection rates of HPV16/18/45 in postmenopausal and premenopausal women were 42.4% and 34.3%, respectively. In the HPV18/45 group, the incidence of HSIL + was 30.0% in postmenopausal women and 15.0% in premenopausal women (P < 0.01). In the HPV 16 + and Other HR-HPV + groups, the incidence of HSIL + in postmenopausal patients was not significantly different from that in premenopausal patients. The incidence of cervical cancer in postmenopausal patients is significantly higher than that in premenopausal patients.Conclusions Colposcopy referral or further biopsy is recommended for all ASCUS patients with HPV16/18/45E6/E7 mRNA positivity and postmenopausal patients with HR-HPVE6/E7 mRNA positivity. For premenopausal ASCUS patients with other HR-HPV E6/E7 mRNA positivity, colposcopy should be performed if possible, depending on the specific situation, to achieve early detection and diagnosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening
    Wang, Hye-Young
    Kim, Hyunil
    Park, Kwang Hwa
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 78 : 22 - 30
  • [42] Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation
    Rahman, Md. Mijanur
    Masum, Md. Habib Ullah
    Parvin, Rehana
    Das, Shuvo Chandra
    Talukder, Asma
    PLOS ONE, 2025, 20 (01):
  • [43] PROGNOSTIC IMPLICATION OF HIGH RISK HUMAN PAPILLOMAVIRUS E6 AND E7 mRNA IN PATIENTS WITH INTRAEPITHELIAL LESIONS OF THE CERVIX IN RELATIONSHIP TO AGE
    Frega, A.
    Lorenzon, L.
    Giovagnoli, M. R.
    De Sanctis, L.
    Fabiano, V.
    Lukic, A.
    Moscarini, M.
    Torrisi, M. R.
    French, D.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2011, 24 (02) : 461 - 470
  • [44] Sensitivity, Specificity, and Clinical Value of Human Papillomavirus (HPV) E6/E7 mRNA Assay as a Triage Test for Cervical Cytology and HPV DNA Test
    Benevolo, Maria
    Vocaturo, Amina
    Caraceni, Donatella
    French, Deborah
    Rosini, Sandra
    Zappacosta, Roberta
    Terrenato, Irene
    Ciccocioppo, Lucia
    Frega, Antonio
    Rossi, Paolo Giorgi
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (07) : 2643 - 2650
  • [45] Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS
    Zhu, Yuanhang
    Ren, Chenchen
    Yang, Li
    Zhang, Xiaoan
    Liu, Ling
    Wang, Zhaoxin
    BMC CANCER, 2019, 19 (1)
  • [46] p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women
    Rossi, Paolo Giorgi
    Carozzi, Francesca
    Ronco, Guglielmo
    Allia, Elena
    Bisanzi, Simonetta
    Gillio-Tos, Anna
    De Marco, Laura
    Rizzolo, Raffaella
    Gustinucci, Daniela
    Del Mistro, Annarosa
    Frayle, Helena
    Confortini, Massimo
    Iossa, Anna
    Cesarini, Elena
    Bulletti, Simonetta
    Passamonti, Basilio
    Gori, Silvia
    Toniolo, Laura
    Barca, Alessandra
    Bonvicini, Laura
    Mancuso, Pamela
    Venturelli, Francesco
    Benevolo, Maria
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (03): : 292 - 300
  • [47] RNA (E6 and E7) Assays versus DNA (E6 and E7) Assays for Risk Evaluation for Women Infected with Human Papillomavirus
    Cattani, Paola
    Siddu, Alessia
    D'Onghia, Sara
    Marchetti, Simona
    Santangelo, Rosaria
    Vellone, Valerio G.
    Zannoni, Gian Franco
    Fadda, Giovanni
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (07) : 2136 - 2141
  • [48] High Risk HPV E6/E7 Oncoprotein Expression in Women with High Grade Squamous Intraepithelial Lesion
    Cordeiro Valenca, Jefferson Elias
    Goncalves, Ana Katherine
    Cotrim Guerreiro da Silva, Ismael Dale
    Eleuterio Junior, Jose
    da Silva, Terezinha Tenerio
    Bruneska, Danyelly
    de Alencar Ximenes, Ricardo Arraes
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2016, 38 (03): : 154 - 159
  • [49] Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer
    Stiasny, Annika
    Kuhn, Christina
    Mayr, Doris
    Alexiou, Christoph
    Janko, Christina
    Wiest, Irmi
    Jeschke, Udo
    Kost, Bernd
    ANTICANCER RESEARCH, 2016, 36 (06) : 3195 - 3198
  • [50] High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis
    Yeo-Teh, Nicole S. L.
    Ito, Yoshiaki
    Jha, Sudhakar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06)